Although FRα is overexpressed in up to 90% of ovarian cancers, including high-grade serous and endometrioid subtypes, it is less prevalent in low-grade and clear cell carcinomas [51,52]. The gene discussed is FOLR1; the disease is clear cell adenocarcinoma.